Esther C Y Lee (Esther Lee)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Systematic Review

Endoplasmic Reticulum

Top Venues

Expert opinion on therapeutic patents

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Kyle D Reichl, Esther C Y Lee, Ariamala Gopalsamy
Synthetic lethality: targeting SMARCA2 ATPase in SMARCA4-deficient tumors - a review of patent literature from 2019-30 June 2023. Expert opinion on therapeutic patents 34 (3) (2024)
Kyle D Reichl, Esther C Y Lee, Ariamala Gopalsamy
Synthetic lethality: targeting SMARCA2 ATPase in SMARCA4-deficient tumors - a review of patent literature from 2019-30 June 2023. Expert opinion on therapeutic patents (2024)
Kyle D Reichl, Esther C Y Lee, Ariamala Gopalsamy
Synthetic lethality: targeting SMARCA2 ATPase in SMARCA4-deficient tumors - a review of patent literature from 2019-30 June 2023. Expert opinion on therapeutic patents 34 (3) (2024)
Esther C Y Lee, Kyle D Reichl, Ariamala Gopalsamy
Synthetic lethality: targeting the SMARCA2 bromodomain for degradation in SMARCA4-deficient tumors - a review of patent literature from 2019-June 2023. Expert opinion on therapeutic patents (2024)
Kyle D Reichl, Esther C Y Lee, Ariamala Gopalsamy
Synthetic lethality: targeting SMARCA2 ATPase in SMARCA4-deficient tumors - a review of patent literature from 2019-30 June 2023. Expert opinion on therapeutic patents 34 (3) (2024)
Esther C Y Lee, Kyle D Reichl, Ariamala Gopalsamy
Synthetic lethality: targeting the SMARCA2 bromodomain for degradation in SMARCA4-deficient tumors - a review of patent literature from 2019-June 2023. Expert opinion on therapeutic patents 34 (4) (2024)
Esther C Y Lee, Kyle D Reichl, Ariamala Gopalsamy
Synthetic lethality: targeting the SMARCA2 bromodomain for degradation in SMARCA4-deficient tumors - a review of patent literature from 2019-June 2023. Expert opinion on therapeutic patents (2024)
Esther C Y Lee, Kyle D Reichl, Ariamala Gopalsamy
Synthetic lethality: targeting the SMARCA2 bromodomain for degradation in SMARCA4-deficient tumors - a review of patent literature from 2019-June 2023. Expert opinion on therapeutic patents 34 (4) (2024)
Kentaro Futatsugi, Shawn Cabral, Daniel W Kung, Kim Huard, Esther C Y Lee, Markus Boehm, Jonathan Bauman, Ronald W Clark, Steven B Coffey, Collin Crowley, Anne-Marie Dechert-Schmitt, Matthew S Dowling, Robert Dullea, James R Gosset, Amit S Kalgutkar, Kou Kou, Qifang Li, Yajing Lian, Paula M Loria, Allyn T Londregan, Mark Niosi, Christine Orozco, John C Pettersen, Jeffrey A Pfefferkorn, Jana Polivkova, Trenton T Ross, Raman Sharma, Ingrid A Stock, Gregory Tesz, Hanna Wisniewska, Bryan Goodwin, David A Price
Discovery of Ervogastat (PF-06865571): A Potent and Selective Inhibitor of Diacylglycerol Acyltransferase 2 for the Treatment of Non-alcoholic Steatohepatitis. Journal of medicinal chemistry 65 (22) (2022)
Esther C Y Lee, Andrew J McRiner, Katy E Georgiadis, Julie Liu, Zooey Wang, Andrew D Ferguson, Benjamin Levin, Moritz von Rechenberg, Christopher D Hupp, Michael I Monteiro, Anthony D Keefe, Allison Olszewski, Charles J Eyermann, Paolo Centrella, Yanbin Liu, Shilpi Arora, John W Cuozzo, Ying Zhang, Matthew A Clark, Christelle Huguet, Anna Kohlmann
Discovery of Novel, Potent Inhibitors of Hydroxy Acid Oxidase 1 (HAO1) Using DNA-Encoded Chemical Library Screening. Journal of medicinal chemistry 64 (10) (2021)